心脏介入治疗进展



心脏介入治疗进展
心脏病介入治疗是指在X-线透视下，通过导管等特殊器材进入人体心脏和大血管、肾血管内治疗心脏病的一种方法，因仅需局部麻醉，操作简便，不需开胸手术和全身麻醉，患者痛苦小、风险小、术后恢复快，并且在紧急情况下(如急性心肌梗死)能迅速达到血管重建，疏通闭塞血管等诸多优点，其应用日益广泛，范围也逐渐扩展至心脏病学的各个领域，目前已囊括大多数心脏疾病。为此CMBI特准备了关于心脏介入治疗相关文献，供大家参考。CMBI也于特别报道的188期作过相关的报道。更多文献，请用相关关键词通过CMBI文献查询获取。
Two-Year Serial Coronary Angiographic and Intravascular Ultrasound Analysis of In-Stent Angiographic Late Lumen Loss and Ultrasonic Neointimal Volume from the TAXUS II Trial Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents Percutaneous revascularization of chronic total occlusions Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden Increased Risk in Patients With High Platelet Aggregation Receiving Chronic Clopidogrel Therapy Undergoing Percutaneous Coronary Intervention Gender-Based Outcomes in Percutaneous Coronary Intervention With Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry) Feasibility of Endovascular Recanalization for Symptomatic Cervical Internal Carotid Artery Occlusion Safety and Efficacy of Sirolimus-and Paclitaxel-Eluting Coronary Stents Interventional Cardiology-Incidence, Timing, and Correlates of Stent Thrombosis With the Polymeric Paclitaxel Drug-Eluting Stent Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus-and Paclitaxel-Eluting Stents Effect of local anesthesia and intravenous sedation on pain perception and vasovagal reactions during femoral arterial sheath removal after percutaneous coronary intervention Coronary stents-A materials perspective Computational stress-deformation analysis of arterial walls including high-pressure response Assessment of Intermediate Severity Coronary Lesions in the Catheterization Laboratory Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents A study comparing the incidence and predictors of creatine kinase MB and troponin T release after coronary angioplasty A Pooled Analysis of Data Comparing Sirolimus-Eluting Stents with Bare-Metal Stents The cost-effectiveness of drug-eluting stents Platelet reactivity in patients with subacute stent thrombosis compared with non–stent-related acute myocardial infarction Long-term clinical outcome of patients treated with β-brachytherapy in routine clinical practice Interventional Cardiology-Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction Incidence, predictors, and outcomes of device failure of X-sizer thrombectomy Randomized Comparison of Sirolimus and Paclitaxel Drug-Eluting Stents for Long Lesions in the Left Anterior Descending Artery Impact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome in Elective Patients Undergoing Multivessel Revascularization With Sirolimus-Eluting Stents Drug-eluting stents for the treatment of bifurcation lesions Effectiveness of Drug-Eluting Stents in Patients With Bare-Metal In-Stent Restenosis Preventing Restenosis Detection of Coronary Microembolization by Doppler Ultrasound in Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Interventions Coronary stents-A materials perspective Catheter-Tip Embolectomy in the Management of Acute Massive Pulmonary Embolism Carotid Stenosis Index Revisited With Direct CT Angiography Measurement of Carotid Arteries to Quantify Carotid Stenosis Long-Term Outcomes of Significant Mitral Regurgitation After Percutaneous Mitral Valvuloplasty Intravascular Device Infections-Epidemiology, Diagnosis, and Management Long-Term Outcomes After Management of Restenosis or Thrombosis of Drug-Eluting Stents Impaired health status in Type D patients following PCI in the drug-eluting stent era Coronary Collateral Function Long After Drug-Eluting Stent Implantation Preventing Restenosis Coronary stents-A materials perspective Value of Platelet Reactivity in Predicting Response to Treatment and Clinical Outcome in Patients Undergoing Primary Coronary Intervention Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation Randomized Double-Blind Comparison of Sirolimus-Eluting Stent Versus Bare-Metal Stent Implantation in Diseased Saphenous Vein Grafts Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock Network Analysis of Human In-Stent Restenosis Late Thrombosis of Drug-Eluting Stents Effect of microvascular reperfusion on prognosis and left ventricular function in anterior wall myocardial infarction treated with primary angioplasty Effect of Clopidogrel With and Without Eptifibatide on Tumor Necrosis Factor-Alpha and C-Reactive Protein Release After Elective Stenting Late stent thrombosis in drug-eluting stents Drug-eluting stent thrombosis Coronary Intervention for Persistent Occlusion after Myocardial Infarction Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation A Randomized Study Comparing Same-Day Home Discharge and Abciximab Bolus Only to Overnight Hospitalization and Abciximab Bolus and Infusion After Transradial Coronary Stent Implantation Update on Bioabsorbable Stents Unprotected Left Main Coronary Intervention with Drug-Eluting Stents Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter Total Occlusion Devices The Pathophysiology of Ischemic Mitral Regurgitation The 2002 European registry of cardiac catheter interventions Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease Role of Embolic Protection and Drug-Eluting Stents Review of Interventional Repair for Abdominal Aortic Aneurysm Predictors of Recurrent In-Stent Restenosis Polymers, Drug Release, and Drug-Eluting Stents Percutaneous Transcatheter Repair for Mitral Regurgitation Percutaneous Implantation of Aortic Valve Prosthesis in Patients with Calcific Aortic Stenosis Outcomes of 6906 Patients Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents New Developments in Coronary Stent Technology Multislice Computer Tomography for Detection of Coronary Artery Disease Magnetic Navigation in Percutaneous Coronary Intervention Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement Endovascular Management of Deep Vein Thrombosis Embolic Protection Devices in Saphenous Vein Graft Interventions Duration of Clopidogrel Therapy with Drug-Eluting Stents Drug-Eluting Stent Restenosis Drug Eluting Stents- Drug-eluting stents for stent thrombosis elevation acute myocardial infarction Drug-eluting stents and stent thrombosis Drug-eluting stent era-will we improve 5-year outcomes Drug Eluting Stents-an evidence-based approach for the use of drug-eluting stents Current Status of Catheter-Based Mitral Valve Repair Therapies Current options, and long-term results for interventional treatment of pulmonary valvar stenosis Coronary Stent Thrombosis Related to Aspirin Resistance Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention Complex Coronary Interventions Carotid Stenting Bifurcation Stenting Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions Vessel Size and Outcome After Coronary Drug-Eluting Stent Placement Variability in Fluoroscopic X-Ray Exposure in Contemporary Cardiac Catheterization Laboratories Unprotected Left Main Coronary Intervention with Drug-Eluting Stents Total Occlusion Devices Thrombus Aspiration Reduces Microvascular Obstruction After Primary Coronary Intervention Thrombus Aspiration Before Primary Angioplasty Improves Myocardial Reperfusion in Acute Myocardial Infarction The Relationship of Body Mass Index to Outcomes after Percutaneous Coronary Intervention The Influence of Peripheral Arterial Disease on Outcomes Regional Transfer Programs for Primary Percutaneous Coronary Intervention. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention Prehospital Electrocardiogram and Early Helicopter Dispatch to Expedite Interfacility Transfer for Percutaneous Coronary Intervention. Predictors of Recurrent In-Stent Restenosis after Beta-Radiation Percutaneous Left and Right Heart Catheterization in Fully Anticoagulated Patients Utilizing the Radial Artery and Forearm Vein Percutaneous Coronary Intervention After Fibrinolysis Long-Term Results After Directional Atherectomy of Femoro-Popliteal Lesions Long-Term Mortality, Cause of Death, and Temporal Trends in Complications after Percutaneous Aortic Balloon Valvuloplasty for Calcific Aortic Stenosis ll Drug-Eluting Stents Are Equal, But Some Drug-Eluting Stents Are More Equal Than Others Intracoronary ST-Segment Shift Soon After Elective Percutaneous Coronary Intervention Accurately Predicts Periprocedural Myocardial Injury. Two-Year Follow-up of Sirolimus-Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery Stenosis Efficacy of Sirolimus-Eluting Stents as Compared to Paclitaxel-Eluting Stents for Saphenous Vein Graft Intervention Analysis of Location and Pattern of Target Vessel Failure in Chronic Total Occlusions after Stent Implantation and Its Potential for the Efficient Use of Drug-Eluting Stents Age-Based Differences of Percutaneous Coronary Intervention in the Drug-Eluting Stent Era Duration of Clopidogrel Therapy with Drug-Eluting Stents Drug-Eluting Stent Restenosis-Incidence, Predictors, Mechanisms, and Treatment Directional atherectomy before stenting versus stenting alone in percutaneous coronary interventions Debate of Adjunctive Pharmacology for Percutaneous Coronary Intervention Debate of Adjunctive Pharmacology for Percutaneous Coronary Intervention-Thrombin Inhibitors and Clopidogrel Are Enough Coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention Clinical Outcomes for Sirolimus-Eluting Stents and Polymer-Coated Paclitaxel-Eluting Stents in Daily Practice Carotid Stenting Bypass Graft Disease-Role of Embolic Protection and Drug-Eluting Stents BioSTAR Evaluation STudy (BEST) Bifurcation Stenting Benefit of Early Invasive Therapy in Acute Coronary Syndromes Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting After Fibrinolysis-Is Cardiac Catheterization the Answer A Subgroup Analysis of the Impact of Prerandomization Antithrombin Therapy on Outcomes in the SYNERGY Trial A Repositionable Valved Stent for Endovascular Treatment of Deteriorated A Novel Contrast Removal System From the Coronary Sinus Using an Adsorbing Column During Coronary Angiography in a Porcine Model Sirolimus-Eluting versus Uncoated Stents in Acute Myocardial Infarction Sirolimus-Eluting Stents at Two Years Role of Prophylactic Intra-Aortic Balloon Pump in High-Risk Patients Undergoing Percutaneous Coronary Intervention Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II) Plaque Volume and Occurrence and Location of Periprocedural Myocardial Necrosis After Percutaneous Coronary Intervention Paclitaxel-Eluting versus Uncoated Stents in Primary Percutaneous Coronary Intervention Is sirolimus better than paclitaxel-A review of the comparative data on drug-eluting stents Incidence of New Brain Lesions After Carotid Stenting With and Without Cerebral Protection Facilitated Percutaneous Coronary Intervention Characterization of Plaque Prolapse After Drug-Eluting Stent Implantation in Diabetic Patients Carotid Artery Stenting The Prognostic Importance of Nonsignificant Left Main Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention Routine Thrombectomy in Percutaneous Coronary Intervention for Acute ST-Segment-Elevation Myocardial Infarction Review of Randomized Clinical Trials of Drug-Eluting Stents for the Prevention of In-Stent Restenosis Periprocedural and Late Consequences of Overlapping Cypher Sirolimus-Eluting Stents Pathology of Drug-Eluting Stents in Humans Impact of Sirolimus-Eluting and Paclitaxel-Eluting Stents on Outcome in Patients With Diabetes Mellitus and Stenting in More Than One Coronary Artery Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary Revascularization Cost Analysis From Two Randomized Trials of Sirolimus-Eluting Stents Versus Paclitaxel-Eluting Stents in High-Risk Patients With Coronary Artery Disease Effectiveness and Safety of Sirolimus Stent Implantation for Coronary In-Stent Restenosis Drug-eluting stents Zotarolimus (ABT-578) eluting stents Sirolimus and Paclitaxel on Polymer-Based Drug-Eluting Stents Role of stent design and coatings on restenosis and thrombosis Role of adjunct pharmacologic therapy in the era of drug-eluting stents Restenosis following implantation of bare metal coronary stents Predictors of Restenosis After Placement of Drug-Eluting Stents Prediction of Left Ventricular Function After Drug-Eluting Stent Implantation for Chronic Total Coronary Occlusions Patient and lesion subsets Mechanisms of controlled drug release from drug-eluting stents Long-term clinical outcomes of patients with multiple risk factors for restenosis receiving drug-eluting stents Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform Local perivascular delivery of anti-restenotic agents from a drug-eluting poly( Formula Not Shown-caprolactone) stent cuff Local and systemic drug competition in drug-eluting stent tissue deposition properties Failures and restenosis Factors governing local pharmacokinetics Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506 Drug-eluting stents Drug-eluting stents-results, promises and problems Drug-eluting stents-A multidisciplinary success story Drug-Eluting Stents Versus Bare Metal Stents in Percutaneous Coronary Interventions Drug-eluting stents studies in mice Drug-Eluting Stents in the Treatment of Intermediate Lesions Drug-eluting stents in diabetics & Complex patient groups Drug-eluting stents for the treatment of in-stent restenosis Drug-Eluting Stent Restenosis Clinical experience and applications of drug-eluting stents in the noncoronary vasculature, bile duct and esophagus Biological aspects of radiation and drug-eluting stents for the prevention of restenosis Adjusted indirect comparison of intracoronary drug-eluting stents A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus A Novel Drug-Eluting Stent Coated With an Integrin-Binding Cyclic Arg-Gly-Asp Peptide Inhibits Neointimal Hyperplasia A new paradigm in controlled drug delivery Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients Rates of Delayed Rebleeding From Intracranial Aneurysms Are Low After Surgical and Endovascular Treatment. Protected Carotid Stenting in High-Risk Patients With Severe Carotid Artery Stenosis N-Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty Mechanisms and Predictors of Carotid Artery Stent Restenosis Intracoronary radiotherapy with a 188Rhenium liquid-filled angioplasty balloon system in in-stent restenosis Initial impact of drug-eluting stent use on the spectrum of patients undergoing percutaneous coronary intervention. Percutaneous Treatment With Drug-Eluting Stent Implantation Versus Bypass Surgery for Unprotected Left Main Stenosis Drug-Eluting Stents in the Treatment of Intermediate Lesions A Randomized Comparison of Sirolimus-Eluting Stent With Balloon Angioplasty in Patients With In-Stent Restenosis Drug-Eluting Stent Restenosis Rescue percutaneous coronary intervention after failed fibrinolytic therapy Two-Year Outcomes After Sirolimus-Eluting Stent Implantation Treatment of unprotected left main coronary artery disease with drug-eluting stents

Last Modified: 2007-04-15